Brand Names:
Adequan


Polysulfated glycosaminoglycan

Polysulfated glycosaminoglycan (PSGAG), sold under the brand name Adequan, is an intramuscular injection for the control of signs associated with non-infectious degenerative and/or traumatic arthritis of the synovial joints. It is most commonly known for it's use in horses and dogs, but it has also shown beneficial for pet poultry as well.

Polysulfated glycosaminoglycan is a semi-synthetic glycosaminoglycan prepared by extracting glycosaminoglycans (GAGs) from bovine tracheal cartilage. GAGs are polysaccharides composed of repeating disaccharide units.

Disclaimer: Use at your own risk. We assume no responsibility for the use of the drug, dosages given and for any misstatement, error, negligent, or otherwise.
  • 1 mg/kg bw IM (A Wonn 2022)
injectableAdequan® Canine Solution 100 mg/mL in a 5 mL preserved multiple dose vial. Each mL of Adequan® Canine contains 100 mg of PSGAG, 0.9% v/v benzyl alcohol as a preservative, and water for injection q.s. to 1 mL. Sodium hydroxide and/or hydrochloric acid added when necessary to adjust pH. The solution is clear, colorless to slightly yellow.